[go: up one dir, main page]

AR009600A1 - SEQUENCE OF NUCLEIC ACID AND AMINO ACIDS RELATED TO HELICOBACTER PYLORI AND VACCINE COMPOSITIONS OF THE SAME. - Google Patents

SEQUENCE OF NUCLEIC ACID AND AMINO ACIDS RELATED TO HELICOBACTER PYLORI AND VACCINE COMPOSITIONS OF THE SAME.

Info

Publication number
AR009600A1
AR009600A1 ARP970105002A ARP970105002A AR009600A1 AR 009600 A1 AR009600 A1 AR 009600A1 AR P970105002 A ARP970105002 A AR P970105002A AR P970105002 A ARP970105002 A AR P970105002A AR 009600 A1 AR009600 A1 AR 009600A1
Authority
AR
Argentina
Prior art keywords
sequence
vaccine compositions
nucleic acid
amino acids
same
Prior art date
Application number
ARP970105002A
Other languages
Spanish (es)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR009600A1 publication Critical patent/AR009600A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Se describen preparaciones recombinantes o sustancialmente puras de polipéptidos de H.pylori. Los ácidos nucleicos que codifican a lospolipéptidos también se describen. Los polipéptidos de H.pylori son utiles para el diagnotico y lascom posiciones para vacuna.Recombinant or substantially pure preparations of H.pylori polypeptides are described. Nucleic acids encoding polypeptides are also described. H.pylori polypeptides are useful for diagnosis and vaccine compositions.

ARP970105002A 1996-10-28 1997-10-28 SEQUENCE OF NUCLEIC ACID AND AMINO ACIDS RELATED TO HELICOBACTER PYLORI AND VACCINE COMPOSITIONS OF THE SAME. AR009600A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73915096A 1996-10-28 1996-10-28
US75973996A 1996-12-06 1996-12-06
US89192897A 1997-07-14 1997-07-14

Publications (1)

Publication Number Publication Date
AR009600A1 true AR009600A1 (en) 2000-04-26

Family

ID=27419246

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970105002A AR009600A1 (en) 1996-10-28 1997-10-28 SEQUENCE OF NUCLEIC ACID AND AMINO ACIDS RELATED TO HELICOBACTER PYLORI AND VACCINE COMPOSITIONS OF THE SAME.

Country Status (19)

Country Link
EP (1) EP0973394A4 (en)
JP (1) JP2001504329A (en)
KR (1) KR20000052831A (en)
CN (1) CN1235513A (en)
AR (1) AR009600A1 (en)
AU (1) AU734052B2 (en)
BR (1) BR9712587A (en)
CA (1) CA2265523A1 (en)
EE (1) EE9900176A (en)
ID (1) ID22065A (en)
IL (1) IL129397A0 (en)
IS (1) IS5005A (en)
NO (1) NO991995L (en)
NZ (1) NZ334568A (en)
PL (1) PL333169A1 (en)
SA (1) SA98180918A (en)
SK (1) SK34699A3 (en)
TR (1) TR199900940T2 (en)
WO (1) WO1998018323A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
US5871749A (en) * 1993-07-27 1999-02-16 Csl Limited Therapeutic treatment of H. pylori associated gastroduodenal disease
DE19730425A1 (en) 1997-07-16 1999-01-21 Henkel Teroson Gmbh Heat-curing laundry-resistant shell sealant
AU4793499A (en) * 1998-07-27 2000-02-21 Aventis Pasteur Limited (chlamydia) antigens and corresponding dna fragments and uses thereof
SE9901548D0 (en) * 1999-04-29 1999-04-29 Astra Ab Helicobacter pylori antigens
GB9914945D0 (en) * 1999-06-25 1999-08-25 Smithkline Beecham Biolog Novel compounds
AUPQ347199A0 (en) * 1999-10-15 1999-11-11 Csl Limited Novel polypeptide fragments
CN101532000A (en) 2000-03-08 2009-09-16 诺维信公司 Variants with altered properties
GB0010371D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
GB0010370D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
EP2695938B1 (en) 2011-03-17 2016-11-30 National UniversityCorporation Mie University Antibody production method
JP6959937B2 (en) * 2015-12-14 2021-11-05 テクニシェ ユニバーシタット ミュンヘン Helicobacter pylori vaccine
CN115724922B (en) * 2022-07-19 2023-08-22 四川大学华西医院 A kind of Helicobacter pylori vaccine recombinant protein antigen TonB and its preparation method and application
CN115581201A (en) * 2022-08-26 2023-01-10 云南省农业科学院花卉研究所 Diploid rose F induced by stem segment as explant 1 -61 plant regeneration method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9300139L (en) * 1993-01-19 1994-07-20 Medicarb Ab Preparation of a new drug

Also Published As

Publication number Publication date
AU5093398A (en) 1998-05-22
EP0973394A1 (en) 2000-01-26
IL129397A0 (en) 2000-02-17
SK34699A3 (en) 2000-04-10
EP0973394A4 (en) 2005-03-30
NZ334568A (en) 2000-04-28
KR20000052831A (en) 2000-08-25
CA2265523A1 (en) 1998-05-07
WO1998018323A1 (en) 1998-05-07
NO991995D0 (en) 1999-04-27
TR199900940T2 (en) 1999-09-21
NO991995L (en) 1999-06-28
BR9712587A (en) 1999-10-26
JP2001504329A (en) 2001-04-03
PL333169A1 (en) 1999-11-22
SA98180918A (en) 2005-12-03
AU734052B2 (en) 2001-05-31
EE9900176A (en) 1999-12-15
ID22065A (en) 1999-08-26
IS5005A (en) 1999-03-18
CN1235513A (en) 1999-11-17

Similar Documents

Publication Publication Date Title
AR009600A1 (en) SEQUENCE OF NUCLEIC ACID AND AMINO ACIDS RELATED TO HELICOBACTER PYLORI AND VACCINE COMPOSITIONS OF THE SAME.
EP0722461A4 (en) Expression of fusion polypeptides transported out of the cytoplasm without leader sequences
AR004668A1 (en) A PURIFIED ISOLATED NUCLEIC ACID, A RECOMBINING VECTOR OF EXPRESSION THAT UNDERSTANDS IT, A CELL THAT INCLUDES SUCH A VECTOR, A METHOD FOR THE PRODUCTION OF A H.PYLORI POLYPEPTIDE, A COMPOSITION OF A VACCINE, A PREPARED COMPOSITION PURIFIED BY H.
AR067658A2 (en) AN IMMUNOGENIC POLYPEPTIDE, A POLINUCLEOTIDE CODIFYING THEM, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE POLYPEPTIDES AND POLYNUCLEOTIDES, XPRESSION VECTORS, VACCINES, A METHOD FOR THE PREPARATION OF SUCH POLYPEPTIDE DIFFUSED POLIPEPTIDE.
KR870700019A (en) Recombinant alveolar surfactant protein
AR006999A1 (en) AN IMMUNOGENIC, THERAPEUTIC OR PROPHYLACTIC COMPOSITION, INCLUDING AN ISOLATED POLYPEPTIDE, AN ISOLATED ANTIBODY THAT IS LINKED TO SUCH A POLYPEPTIDE AND A VACCINE THAT UNDERSTANDS IT.
ES2056817T3 (en) TRANSFORMATION OF TRICHODERMA.
KR900700469A (en) Urethane-protected amino acid-N-carboxy anhydride
ES8606399A1 (en) A PROCEDURE FOR PREPARING A PEPTIDE THAT HAS AN INFLUENCE ON THE FUNCTION OF THE PITUITARY GLAND
NZ332565A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
PE91998A1 (en) METHOD FOR THE SYNTHESIS OF ANALOGS OF PARATHYROID HORMONE AND PEPTIDE RELATED TO PARATHYROID HORMONE
BR9306272A (en) Peptide and pharmaceutical composition
DK611386A (en) RECOMBINANT HUMANT FSH, PROCEDURE FOR PREPARING IT AND VECTORS AND CELLS FOR USING THE PROCEDURE
DE3881023D1 (en) PROTEINS, EXPRESSION VECTORS, CONTAINING DNA ENCODING SUCH PROTEINS, AND CELLS CONTAINING SUCH EXPRESSION VECTORS.
AR013618A1 (en) METHOD AND COMPOSITIONS FOR THE DISTRIBUTION AND EXPRESSION OF NUCLEIC ACIDS OF INTERFERON
BR9714133A (en) isolated nucleic acid, molecule thereof, probe, recombinant expression vector, cell, polypeptide, fusion protein vaccine formulation and processes for producing a h. pylori, to detect the presence of a helicobacter nucleic acid in a sample, to treat or reduce a risk of infection by h. pylori in an individual and to produce a vaccine formulation
DK0463053T3 (en) Preparation and use of anthelmintic agents and protective immunogens
DK527187A (en) GONADOLIBERINE ANALOGUE, PROCEDURE FOR THEIR PREPARATION AND THEIR USE AS MEDICINES
DE3650035D1 (en) THF compositions.
DE3686257D1 (en) PRODUCTION OF POLYPEPTIDES.
DK1612555T3 (en) Cryptic peptides for use in inducing immunological tolerance
ID23052A (en) VACCINE COMPOSITION THAT CONTAINS POLYPEPTIDE OF FLGE HELICOBACTER PYLORI
MX9709846A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics.
DE69012328D1 (en) SRIF RELATED PEPTIDES AND THEIR USE.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal